Healthy people need a healthy planet. Proud that #MSD announced today ambitious goals to reach carbon neutrality in our operations and 100% renewable energy by 2025 ! #sustainability#climatechange
6 months in Switzerland 🇨🇭 already! Time flies when you are working with a great team on an important mission.
Thank you PharmaBoardroom for the opportunity to share my reflections on Switzerland as life science hub and our key priorities at #MSDSwitzerland#FutureOfPharma
It is always a pleasure to be in Norway! I was thrilled to present the research on Lung Cancer in Europe. The momentum for change is here! The report on the first phase of the research is available: https://t.co/9vnDXiVAz2
Helseøkonom Brieuc Van Damme fra Belgia viser forskjellen på helsenæringen i Norge og Belgia per 2017: 1502 kliniske studier i Belgia vs 121 i Norge: Vi har noe å strekke oss etter #helsenæring@DagensMedisin @arendalsuka @OsloCancer
@JEinarsson på debatten til @DagensMedisin mener Norge bør ta i bruk den belgiske modellen for innovasjon - baserer seg på samarbeid mellom industri og myndigheter #helsenæring
En stor internasjonal undersøkelse av lungekreft i 27 land viser at lungekreft tar livet av brystkreft, tarmkreft og prostatakreft tilsammen. Mary Bussell fra @TheEIU viser at Norge kan gjøre mye bedre i sin forebygging og behandling @Kreftforeningen@DagensMedisin @arendalsuka
Looking forward to @arendalsuka and preparing for the @AmChamNorway debate on building the Norwegian healthcare industry. Hope to see you there😀 https://t.co/6BStddz2Z9
A solid blog from Alexander Roediger on transparency across all its meanings in the pharma world and how our current policy discussions often split between grand standing and evidence-based policy making. Government actions have consequences. @EFPIA
https://t.co/UsheBFl0ya
Gratulerer med dagen! Kliniske studier gir pasienter som trenger det tidlig tilgang til ny behandling og bygger viktig kompetanse i helsevesenet-#WhyWeWork4Life